Replies to post #166874 on Anavex Life Sciences Corp (AVXL)

[OFP]

" the BIIB people to evaluate a treatment that will potentially undercut 70% of BIIB gross rev? Not gonna happen."--agree nidan---we know--it's all about the bottom line--profits dictate---perhaps we will develop 2-73 for MS on our own (after we have success with AD)---takes time !!!!!

BP is so devious!

...and I'm sure that no other company would have an interest in undercutting 70% of BIIB's gross revenues. My experience is that they always respect each other's revenue streams and wouldn't even think about impairing their business, right?